🔴 Sionna Therapeutics is trading 10.2% down today amid broad biotech and market selloff

Sionna Therapeutics is trading at $3.35, down 10.19%, amid broad biotech and market weakness.

• The supplied sector context reports biotech ETF XBI down 5.19%, while major indexes also fell sharply.
• No company-specific announcement explaining the November 5 decline was identified; the latest release concerned upcoming investor conferences.
• The move points to sector and market pressure rather than a newly reported Sionna-specific catalyst.